Project Grant RF1AG075055
Award Date
8/1/22
Completion Date
7/31/25
Dollars Obligated
$3M
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Massachusetts, USA
Similar Awards
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $455,009 to The General Hospital Corporation (doing business as Massachusetts General Hospital) to develop a novel [18F]-labeled amphiphilic PET probe that can cross the blood-brain barrier and track CD206+ microglia/macrophages in Alzheimer's disease. The goal is to create a non-invasive imaging method to detect anti-inflammatory M2-like microglia and macrophages, which play a key role in...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $426,250 to Wake Forest University Health Sciences to develop and evaluate a novel positron emission tomography (PET) radiotracer, [11C]TM-N1324, to measure levels of the G-protein coupled receptor GPR39 in rodent models and postmortem human brain tissues of Alzheimer's disease (AD). The project aims to establish the utility of this PET imaging approach for quantifying GPR39, which is implicated...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will fund a pilot study to evaluate the feasibility of using non-invasive neuroimaging techniques to monitor the metabolic and vascular functions of the brain and heart in a mouse model of Alzheimer's disease (AD). The $332,096 award, with a performance period from July 2024 to June 2026, will be made to The General Hospital Corporation (doing business as Massachusetts General Hospital). The research...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to Emory University supports the development of a novel positron emission tomography (PET) ligand for imaging poly(ADP-ribose) polymerase-1 (PARP1) in the brain. The $782,495 award aims to design and evaluate a focused library of PARP1-specific modulators with optimized binding affinity and brain kinetics, suitable for radiolabeling and quantifying PARP1 expression changes in rodents, non-human primates,...
The National Institute on Aging (NIA) awarded a $1,783,700.00 Project Grant under the Aging Research program (CFDA 93.866) to the University of Illinois to develop novel blood-brain barrier permeable multimodal imaging agents for the diagnosis of neurodegenerative diseases, with a focus on Alzheimer's disease and related dementias. The 3-year grant aims to employ organic and inorganic chemical design principles to generate diagnostic agents capable of detecting protein aggregation,...
This Project Grant award of $837,500 from the National Institute on Aging (CFDA 93.866 - Aging Research) will support research to characterize and validate the use of the PET radiotracer [18F]3F4AP for detecting and quantifying demyelination and cerebral perfusion in Alzheimer's disease (AD), mild cognitive impairment (MCI), and cognitively normal individuals. The research will perform the first full pharmacokinetic evaluation of this tracer in human subjects with AD and MCI, and validate...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to The Trustees of the University of Pennsylvania provides $812,030 to develop and optimize noninvasive imaging biomarkers to track neuroinflammation in the early stages of Alzheimer's disease (AD). The research aims to investigate the relationship between astrocytic acetate metabolism and astrocyte reactivity, characterize spatiotemporal patterns of neuroinflammation and brain glucose...
This $4.49 million project grant from the National Institutes of Health's National Institute on Aging will fund research at The Washington University to investigate the relationship between amyloid plaque deposition, cellular metabolic dysfunction, and functional brain organization in Alzheimer's disease (AD) mice models. Over three years, the researchers will use multi-photon fluorescence lifetime imaging microscopy, multi-parametric photoacoustic microscopy, and wide-field optical imaging to...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $233,402 to the University of Missouri System to develop new F-18 labeled positron emission tomography (PET) radiotracers targeting the alpha-2C adrenergic receptor. The goal is to create improved radiotracer candidates based on the existing ORM13070 compound, with the intent of advancing preclinical evaluation and potential future clinical applications for diagnosing and studying conditions...
This $4.46 million project grant from the National Institute on Aging, part of the Department of Health and Human Services, supports research under the Aging Research program (CFDA 93.866) to develop a new in vivo magnetic resonance imaging biomarker for early detection of Alzheimer's disease neurodegeneration. Specifically, the awardee, Washington University, will utilize quantitative gradient recalled echo MRI techniques to identify two types of hippocampal tissue in preclinical and mild...